Good Lay Summary Practice

On 4 October 2021 the European Commission added guidance to Chapter V of EudraLex Volume 10.

This “Good Lay Summary Practice” (“GLSP”) provides recommendations on how to prepare, write, translate, and disseminate summaries of clinical trial results in lay language. This is a mandatory requirement laid out in Regulation (EU) No. 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use (“EU CTR”) and a transparency obligation to all trial participants and the interested public.

Read the pdf 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /